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Cardiogenic Shock
Brad Closson BSN, RN, CCRN
Otterbein University, Westerville, Ohio
Introduction
What is Cardiogenic
Shock?
•

Cardiogenic shock is defined as a
state in which ineffective cardiac
output leads to inadequate tissue
perfusion (van Diepen et al., 2017).

•

Defining characteristics include:
•
Hypotension
•
Low cardiac
output/index
•
End-organ
hypoperfusion
(Brener et al., 2020)

•

Acute Myocardial Infarction (AMI)
with left ventricular dysfunction is
the leading cause of cardiogenic
shock in the United States.
(Mandawat & Rao, 2017)

-

Pathophysiological Processes
Underlying
Signs and Symptoms
Pathophysiology
1.
Hemodynamic Criteria:
Systolic blood pressure (SBP) <90
mmHg for greater than 30 minutes
•
Use of vasopressors or inotropic
support to maintain SBP >90 mmHG
•
Reduced cardiac output, 2.0-2.2
L/min/m2 with vasopressor and/or
inotropic support
(Shah et al. ,2019)
2.
Signs of end-organ hypoperfusion
•
Tachycardia
•
Low urine output
•
Altered mental status
•
Pale, cool, clammy peripheries
•
Increase lactate levels
•
Low mixed venous saturation
(<65%)
•
Shortness of breath
(Shah et al. ,2019)
•

Acute myocardial infarction
(AMI) accounts for 80% of
cardiogenic shock cases
(Brener et al., 2020)
Cardiac ischemia secondary
to AMI causes left ventricular
dysfunction/failure and
decreased cardiac stroke
volumes (van Diepen et al.,
2017)
Diminished cardiac output
and hypotension refractory to
fluid resuscitation lead to
tissue hypoperfusion and
ischemia (Vahdatpour et al.,
2019)
Tissue ischemia causes
compensatory peripheral
vasoconstriction that
increases cardiac workload
and worsens cardiac ischemia
(Vahdatpour et al., 2019)
Compensatory catecholamine
release to stimulate cardiac
contractility causes further
stress upon the damaged
myocardium (Vahdatpour et
al., 2019)
Increased cardiac workload
and stress potentiates cardiac
injury and ischemia causing
worsened shock state (
Noncoronary related
myocardial injury to valves,
pericardium, or electrical
pathways can also lead to
impaired cardiac function and
cardiogenic shock (Brener et
al., 2020)
Chronic heart failure (CHF)
with acute decompensation
may also present in
cardiogenic shock state

•

•

•

•
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“Potential hemodynamic presentations of cardiogenic shock.
CI indicates cardiac index; PCWP, pulmonary capillary wedge pressure; and SVRI,
systemic vascular resistance index” (Van Diepen et al., 2017, p. 235).
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The cyclical nature of cardiogenic shock leads to progressive cardiac dysfunction
and worsened cardiac and tissue ischemia (Shah et al., 2019) In normal cardiac
physiology, the supply and demand of oxygen to the heart and body is
autoregulated by multiple compensatory mechanisms. In cardiogenic shock,
homeostasis is disrupted and compensatory mechanisms such as peripheral
vasoconstriction and catecholamine release cause increased myocardial demand
which worsens primary insult to the heart (Vahdatpour et al., 2019). Continued
and worsening damage of heart tissue exacerbates cardiac dysfunction causing
vital end-organ failure and high mortality rates (Shah et al., 2019)

•

•

Treatment of cardiogenic shock focuses on treating/reversing the underlying
causative process and supportive therapies
•
Coronary reperfusion and revascularization for acute myocardial infarction
related cardiogenic shock (van Diepen et al., 2017)
•
Supportive therapies include:
•
Oxygen administration and mechanical ventilation (Vahdatpour et al.,
2019)
•
Medication and/ or mechanical blood pressure support (Uhlig et al., 2020)
•
Mechanical support devices include:
•
Inta-aortic balloon pump (IABP)
•
Impella
•
Vascular assistive device (VAD)
•
Extracorporeal membrane oxygenation
(ECMO)
•
Tandemheart
•
Fluid resuscitation with goal of euvolemia (Shah et al., 2019)

•

•

•

•

•

Admission to critical care unit is
essential to treat and monitor
hemodynamic instability in
addition to general critical care
interventions (Shah et al., 2019)
Early identification and
treatment of cardiogenic shock
are paramount to the success of
interventions (Mandawat & Rao,
2017)
Models of care should include a
multidisciplinary care team
specifically designated for
patients with cardiogenic shock
(van Diepen et al., 2017)
Tertiary care centers with
cardiac specialists should be
utilized as they have the
expertise and resources
available to treat the
complexities of cardiogenic
shock (van Diepen et al., 2017)

Frequent monitoring of intra-cardiac pressures is recommended with the use of
pulmonary artery catheter (Brener et al., 2020)

Conclusion

In CHF, chronic upregulation
of renin-angiotensinaldosterone system causes
ventricular hypertrophy
leading to cardiac dysfunction
(Brener et al., 2020)

•

Cardiogenic shock is a complex
state of hypotension and low
cardiac output leading to tissue
hypoperfusion (Brener et al.,
2020)

•

Treatment of the cyclical nature
of cardiogenic shock is focused
on fixing the underlying issue
and supportive therapies (van
Diepen et al., 2017)

•

Why Cardiogenic Shock?

Despite advances in modern medicine, mortality in patients with acute myocardial infarction complicated by
cardiogenic shock is approximately 50% (Shah et al., 2019).
In contrast to other acute cardiac conditions, cardiogenic shock does not have precise evidence-based practice
protocols that improve outcomes and lacks definitive treatment strategies (Uhlig et al., 2020).
Continued research is necessary to advance current clinical practices and treatment options (Shah et al., 2019).
Clinicians who manage patients with cardiogenic shock must be aware of the complexities involved.

•

Treatment
•

•
“Physical findings suggestive of the ventricle primarily involved in cardiogenic
shock. Both sides often contribute to the clinical presentation and physical exam
findings” (Vahdatpour et al., 2019, p.3).

Implications for
Nursing Care

Significance of Pathophysiology

Further research is necessary to
understand cardiogenic shock
and evaluate evidence-based
interventions that improve the
high mortality rates of
cardiogenic shock (Uhlig et al.,
2020)
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“Potential cardiogenic shock care pathway” (van Diepen et al., 2017, p. 242).
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